Find investors who align with your industry, stage, and vision. Unlock John Dyson’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors todayJohn Dyson is a Venture Capital, Private Equity Firm based in Melbourne, Victoria, Australia with a diverse investment portfolio that includes companies such as Monitoring Division, Impedance Cardiology Systems, ImpediMed, ZoomSystems, Austhink Software, Quickcomm Software Solutions, atmail, Protagonist Therapeutics, AusraDistra, Schroders Australia, 5th Finger, Evostor, StyleTread, Aruspex, Engana Pty, KPMG Corporate Advisory Services, Qs Semiconductor Corporation, Audinate, Holly Connects, DesignCrowd, DorsaVI, Ourcast, Nitro, Xelor Software, Aktana, Intersection Medical Inc, BugHerd, UpGuard, Scalify, StreamShark, Bubble Gum Interactive, Marani, Nomura Australia, MuriGen, Ofidium, ICIX, G2 Microsystems, MetaCDN, . Over time, John Dyson has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether John Dyson is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Drug Discovery, Email, Autoimmune Diseases, Databases, Messaging, Wellness, Enterprise Software, Immunotherapy, Design, Life Science, Engineering, Crowdsourcing, Education, Artificial Intelligence (AI), Information Technology (IT), Marketplace, Analytics, Cloud Computing, Mobile, Bioinformatics, Software, Biotechnology, Genomics, Productivity Software, Clinical Trials, Consumer Internet, Research, Personalized Medicine, Web Development, Health Diagnostics, Developer Tools, Medical, SaaS, Information Technology, B2B, Molecular Diagnostics, Media and Entertainment, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with John Dyson, as their portfolio suggests a familiarity and interest in this area.
Understanding John Dyson’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today